KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Debt Ratio (2019 - 2025)

Historic Debt Ratio for Vir Biotechnology (VIR) over the last 5 years, with Q1 2025 value amounting to 0.01.

  • Vir Biotechnology's Debt Ratio changed N/A to 0.01 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.01, marking a year-over-year change of. This contributed to the annual value of 0.01 for FY2024, which is N/A changed from last year.
  • As of Q1 2025, Vir Biotechnology's Debt Ratio stood at 0.01.
  • Vir Biotechnology's Debt Ratio's 5-year high stood at 0.06 during Q3 2021, with a 5-year trough of 0.01 in Q4 2024.
  • Its 3-year average for Debt Ratio is 0.03, with a median of 0.02 in 2021.
  • The largest annual percentage gain for Vir Biotechnology's Debt Ratio in the last 5 years was 25433.4% (2021), contrasted with its biggest fall of 419.04% (2021).
  • Quarter analysis of 3 years shows Vir Biotechnology's Debt Ratio stood at 0.06 in 2021, then crashed by 79.72% to 0.01 in 2024, then grew by 16.56% to 0.01 in 2025.
  • Its last three reported values are 0.01 in Q1 2025, 0.01 for Q4 2024, and 0.06 during Q3 2021.